18F-mFBG PET Imaging in the Evaluation of Neuroblastoma
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Neuroblastoma
Related studies linked through entity extraction aliases.
Β3-adrenoreceptor As Prognostic Marker in Neuroblastoma and Ewing Sarcoma
- Status
- COMPLETED
- Phase
- NA
Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
- Status
- RECRUITING
- Phase
- NA
Accurate Diagnosis and Grading of Pediatric Solid Tumors Based on Pathological Large Models
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With Neuroblastoma
- Status
- RECRUITING
- Phase
- NA
Interest of Preoperative Arteriography to Identify the Adamkiewicz Artery Before Surgery for Basi-thoracic Neuroblastic Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Study on the Efficacy of GD2-CAR T Cells in the Treatment of Neuroblastoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Biomarkers of Resiliency In Childhood Cancer Surgery
- Status
- RECRUITING
- Phase
- N/A
Agnostic Therapy in Rare Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Phase I Study of Umbilical Cord Blood Natural Killer (NK) Cell Therapy for Children With High-risk, R/R Neuroblastoma.
- Status
- RECRUITING
- Phase
- PHASE1
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma
- Status
- RECRUITING
- Phase
- N/A
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE2
N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE2
Identification of New Gene Spliceosomes in Neuroblastoma
- Status
- RECRUITING
- Phase
- N/A
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE1
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
- Status
- RECRUITING
- Phase
- PHASE2